-
FDA stiff-arms Sanofi and Lexicon's Type 1 diabetes hopeful Zynquista
fiercepharma
March 23, 2019
The FDA stiff-armed Sanofi and Lexicon's diabetes drug Zynquista on Friday, darkening the companies' hopes of launching the drug for Type 1 diabetes this year.
-
EU regulators expand Praluent’s label
pharmatimes
March 19, 2019
European regulators have approved a new indication for Regeneron and Sanofi’s Praluent, allowing its use to cut cardiovascular risk in adults with established atherosclerotic CV disease (ASCVD).
-
Regeneron/Sanofi wins US approval for expanded use of skin drug
expressbpd
March 14, 2019
The US Food and Drug Administration said it approved expanded use of Regeneron Pharmaceuticals Inc and Sanofi SA’s eczema drug Dupixent to include patients aged between 12 and 17
-
Sanofi, Regeneron's Dupixent gains expanded approval in US for certain adolescents with atopic dermatitis
firstwordpharma
March 12, 2019
Sanofi and Regeneron Pharmaceuticals on Monday announced that the FDA has expanded approval of Dupixent (dupilumab) to include use in adolescents aged 12 to 17 years with moderate-to-severe atopic dermatitis that is not adequately controlled with topical
-
FDA advisory panel recommends against use of Sanofi's dengue vaccine Dengvaxia in adults
biospectrumasia
March 11, 2019
An FDA advisory committee voted 7-6, with one abstention, that data provided by Sanofi do not support the effectiveness of the drugmaker's dengue vaccine Dengvaxia in patients aged nine to 45 years living in endemic areas who were previously diagnosed wit
-
Now that Lilly has a cheaper generic Humalog, will Novo Nordisk and Sanofi follow?
fiercepharma
March 08, 2019
Caught by an outcry over high insulin prices, Eli Lilly recently unveiled an authorized generic version of its Humalog insulin at half the price of the original brand.
-
Lilly to sell generic Humalog insulin at half price
pharmaphorum
March 07, 2019
Eli Lilly has responded to criticism of high prices for insulin products in the US by launching a cut-price version of its Humalog brand.
-
Sanofi, boosted by partnerships, lays out connected tech ambitions in diabetes
fiercepharma
March 07, 2019
Technology solutions are key to the future of diabetes—especially personalized, "smart" connected tech.
-
Sanofi appoints New General Manager China
biospectrumasia
March 04, 2019
Hornstein was the General Manager and Country Chair of Sanofi Brazil for the last four years.
-
Sanofi executives face criminal charges in Philippines over deaths of children given dengue vaccine Dengvaxia
firstwordpharma
March 03, 2019
Regulators in the Philippines said Friday that they plan to file criminal charges against executives from Sanofi, as well as current and former health officials in the country, over the deaths of children given the company's dengue vaccine Dengvaxia.